Verified65% confidenceOpinionExact time
The application of artificial intelligence in protein structure prediction, target screening, and clinical trial design is compressing the drug development cycle.
3
Sources
65%
Confidence
Medium-term (~90 days)
Relevance
9/11/2026
First Seen
Valid until: 12/10/2026
Sources
Related Entities
Related Claims
UnverifiedAI-assisted discovery has made substantive progress in areas such as protein structure prediction, materials science, and mathematical conjecture verification.77% similarUnverifiedAI models can directly predict ADMET properties based on molecular structure, thereby screening out candidates with poor druggability at an early stage.76% similarVerifiedAI has entered pharmaceutical segments including drug discovery, molecular screening, formulation development, real-world research, and pharmacovigilance.75% similarVerifiedAlphaFold is an AI model applied to protein structure prediction, representing the application of AI in scientific research at the level of specific specialized models.74% similarUnverifiedAI agents are expected to significantly compress the hypothesis–experiment–validation cycle in scientific discovery and enable parallel exploration of multiple hypotheses.73% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/909530API
curl https://kongchang.com/api/v1/knowledge/claims/909530MCP
get_claim(id=909530)